Clinical Trial Update: Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

An update on a Phase 3 safety and efficacy study of bendamustine for non-Hodgkin lymphoma, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)

Snippet

Sponsor: Shandong Lanjin Pharmaceuticals Co.,Ltd | Conditions: Non-Hodgkin Lymphoma by Clinical Course | Phase 3 | Status: UNKNOWN